Lantus® SoloStar Pens for Type 1 and Type 2 Diabetes

What Lantus Is and How It Works

Insulin glargine is a long-acting basal insulin used once daily. Lantus® insulin glargine SoloStar pens provide steady 24‑hour background insulin to help manage blood glucose. This page explains how the therapy fits into care, what to know before use, and how to access it, including options that Ships from Canada to US and ways to handle costs without insurance. CanadianInsulin.com is a prescription referral platform. We verify prescriptions with your prescriber when required, and licensed Canadian pharmacies dispense your order.

This medicine releases slowly after subcutaneous injection. It helps control fasting and between‑meal glucose. It is not for treating sudden high blood sugar or ketoacidosis. Use a rapid‑acting insulin for meals and corrections if prescribed. Follow your clinician’s instructions and the official label.

Who It’s For

This treatment is indicated for adults with type 2 diabetes. It is also indicated for patients with type 1 diabetes who are at least 6 years old, used with mealtime insulin. People with a history of severe hypoglycemia or insulin allergy should discuss risks with a healthcare professional. It is not for intravenous use, not for insulin pumps, and not for episodes of diabetic ketoacidosis.

Tell your prescriber about pregnancy or plans to conceive, kidney or liver problems, and all other medicines you take. Extra caution may be needed in older adults and those at higher risk of hypoglycemia.

Dosage and Usage

Use this long‑acting insulin once daily at the same time each day unless your prescriber advises otherwise. Inject into recommended sites such as abdomen, thigh, or upper arm. Rotate sites to reduce skin changes. Do not inject into areas that are tender, thickened, or scarred.

General steps with the SoloStar pen include: attach a new sterile needle for every use, prime per the device instructions, dial your dose, insert the needle into subcutaneous tissue, press and hold the injection button until dosing completes, then keep the needle in place for several seconds before withdrawing. Dispose of the needle safely afterward.

Do not mix this insulin with other insulins. Do not share pens or needles. If your meals, activity, or illness change, your insulin needs may change; speak with your prescriber for guidance. Always review the patient information leaflet for device‑specific steps.

Strengths and Forms

This therapy is supplied as prefilled disposable pens. Each SoloStar pen contains 3 mL total solution. Common retail packaging includes a 5‑pen carton. Availability may vary by pharmacy and market.

• Concentration: 100 units/mL (U‑100) solution
• Presentation: SoloStar disposable prefilled pens
• Common pack: 5 pens per box

Many patients prefer a pen format for convenience. Some choose an Insulin Pens category option that supports discreet use and straightforward dosing.

Insulin glargine pens 5 pack options may be suitable for multi‑month fills when supported by your prescription.

Missed Dose and Timing

If you miss a dose, take it as soon as you remember the same day. If it is almost time for your next dose, skip the missed dose and resume the usual schedule. Do not take two doses at once. Monitor for signs of low blood sugar and keep a source of fast‑acting carbohydrate on hand. Ask your healthcare professional if frequent dosing errors occur.

Storage and Travel Basics

Unopened pens should be kept in the refrigerator until first use and protected from light. Do not freeze. If a pen has been frozen, discard it. After first use, keep the pen at room temperature as directed on the label and away from heat and direct light. Discard the in‑use pen on the labeled in‑use day limit even if insulin remains. Keep out of reach of children and pets.

For travel, carry your insulin and supplies in your hand luggage. Use a protective case to prevent damage. Pack extra pen needles and a backup meter or sensors as instructed. Bring a copy of your prescription and a travel letter if needed. When temperature conditions are expected to vary, use insulated carriers. For additional practical tips, see Insulin Dosage Chart or device guidance such as How To Use Insulin Pen. A micro trust cue: encrypted checkout is used to protect your information.

Pen Handling and Sharps Disposal

Before each injection, always attach a new needle. Prime the pen according to the user manual to ensure insulin flow. Confirm the dose on the dial before injecting. Insert the needle fully into the subcutaneous tissue and keep steady pressure on the button until the dose counter returns to zero. Count slowly before removing the needle to help deliver the full dose.

Use a puncture‑resistant sharps container for used needles. Do not recap needles to avoid accidental sticks. Follow local guidelines for sharps disposal. Keep your device clean and dry; wipe the outside with a damp cloth if needed. Do not lubricate any parts or attempt to refill the disposable pen.

Benefits

This basal insulin provides steady background coverage over 24 hours. It can reduce glucose variability when used as directed. The pen design can simplify daily dosing routines, support small dose adjustments, and may reduce preparation steps compared with vials and syringes.

When used with a complete diabetes plan, the treatment can help maintain fasting and between‑meal targets set by your clinician. Consistency in timing, meal planning, and monitoring supports predictable results.

Side Effects and Safety

• Low blood sugar: shakiness, sweating, dizziness, hunger, or confusion
• Injection site reactions: redness, swelling, or itching
• Weight gain: may occur with sustained use
• Edema: fluid retention can happen in some people
• Skin changes: lipodystrophy at repeated sites

Serious effects can include severe hypoglycemia, hypokalemia, and allergic reactions. Thiazolidinediones taken with insulin may increase the risk of fluid retention or heart failure. Seek urgent care for severe symptoms such as fainting, seizures, or trouble breathing. Review the Medication Guide for complete safety information.

Drug Interactions and Cautions

Some medicines can raise or lower insulin needs. Examples include corticosteroids, certain diuretics, oral diabetes agents, GLP‑1 therapies, ACE inhibitors, and alcohol. Beta blockers can mask warning signs of hypoglycemia. Always tell your clinician about all prescription drugs, OTC products, and supplements you take. Monitor glucose more often when starting or changing therapies.

What to Expect Over Time

Your prescriber may adjust your regimen to meet individualized targets. Many people use this therapy as a once‑daily basal in a multiple‑daily‑injection plan or with oral agents. Expect your care team to review patterns from meters or CGMs, meal timing, activity, and overnight glucose. Keep a simple log or share device downloads to support decisions. Consistent timing and technique can improve day‑to‑day stability.

Compare With Alternatives

Other long‑acting basal options are available. A similar glargine product is Buy Basaglar Online. An ultra‑long option is Tresiba Flextouch Pens. Your clinician can help decide which profile aligns with your goals and daily schedule.

Pricing and Access

Many patients look for predictable spending, including out‑of‑pocket planning. You can compare pack sizes, check current cash options, and see Lantus SoloStar Canadian pricing context across suppliers. If you plan a larger fill, a 5×3 mL pen pack may reduce refill runs. We offer category browsing for supplies in Diabetic Insulin Supplies and therapies in Insulin Medication. For broader deal updates, see Bulk Savings. For cross‑border convenience, US shipping from Canada is available for eligible orders. You can Order insulin glargine pens online after your prescription is validated.

Availability and Substitutions

Packaging and inventory may vary by dispensing pharmacy. If the requested pack or pen style is not available, your prescriber may suggest a therapeutically appropriate alternative or an equivalent schedule. If your prescription supports it, you can Order Lantus SoloStar pen 3 mL cartons or other allowed pack sizes. Discuss any substitution questions with your clinician and pharmacist before changes.

Patient Suitability and Cost-Saving Tips

Good candidates are adults with type 2 diabetes needing basal insulin and patients with type 1 diabetes aged 6 and up who need background coverage. Those who experience frequent lows, significant renal or hepatic impairment, or difficulty recognizing hypoglycemia should review risks closely with their healthcare professional.

• Multi‑month fills: align with prescriber and travel plans
• Smart reminders: set calendar alerts for renewals
• Site rotation: reduce skin changes and variability
• Meter or CGM review: share trends with your prescriber
• Supplies on hand: extra needles and sensors if used

If cost is a concern, ask about switching to the most efficient pack size your prescription allows. Planning ahead helps avoid urgent pharmacy runs.

Questions to Ask Your Clinician

• Starting dose plan: how to time and monitor safely
• Hypoglycemia steps: what to do and when to seek help
• Mealtime coverage: how to pair with rapid‑acting insulin
• Exercise and illness: how to adjust monitoring
• Travel guidance: storage, documentation, and supplies

Authoritative Sources

See the official label and device instructions for complete details:

• FDA DailyMed
• Sanofi
• Health Canada DPD

To review vial‑and‑syringe options or combination therapies, explore Type 2 Diabetes learning pages and related pen technique resources above.

Ready to proceed? You can review pack sizes, submit your script, and track fulfilment with express, cold-chain shipping and US delivery from Canada. This content is for general information and does not replace your clinician’s advice or the approved label.